Back
Seres Therapeutics Stock Price Chart

Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
MCRB
Seres Therapeutics
Last Price:
$0.75
Seasonality Move:
-0.88%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and MCRB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Seres Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.72 | Buy |
20-day SMA: | 0.76 | Sell |
50-day SMA: | 0.8 | Sell |
200-day SMA: | 0.88 | Sell |
8-day EMA: | 0.71 | Buy |
20-day EMA: | 0.74 | Sell |
50-day EMA: | 0.78 | Sell |
200-day EMA: | 0.96 | Sell |
Seres Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 48.24 | Sell |
Chaikin Money Flow: | 628322 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.71 - 0.81) | Sell |
Bollinger Bands (100): | (0.71 - 0.89) | Sell |
Seres Therapeutics Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Seres Therapeutics Stock
Is Seres Therapeutics Stock a Buy?
-
Seres Therapeutics share price is 0.74 while MCRB 8-day simple moving average is 0.72, which is a Buy signal.
-
The stock price of MCRB is 0.74 while Seres Therapeutics 20-day SMA is 0.76, which makes it a Sell.
-
Seres Therapeutics 50-day simple moving average is 0.80 while MCRB share price is 0.74, making it a Sell technically.
-
MCRB stock price is 0.74 and Seres Therapeutics 200-day simple moving average is 0.88, creating a Sell signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
40
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy or a Sell?
-
Seres Therapeutics stock is rated a SellThe current Seres Therapeutics [MCRB] share price is $0.74. The Score for MCRB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics Stock Info
Market Cap:
128.7M
Price in USD:
0.74
Share Volume:
685.9K
Seres Therapeutics 52-Week Range
52-Week High:
1.53
52-Week Low:
0.54
Sell
40
Seres Therapeutics (MCRB)
is a Sell
Seres Therapeutics Share Price Forecast
-
What is the Seres Therapeutics stock price today?The Seres Therapeutics stock price is 0.74 USD today.
-
Will MCRB stock go up or go down?Seres Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Seres Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics is overvalued.
Is Seres Therapeutics Stock a Buy?
-
Seres Therapeutics share price is 0.74 while MCRB 8-day exponential moving average is 0.71, which is a Buy signal.
-
The stock price of MCRB is 0.74 while Seres Therapeutics 20-day EMA is 0.74, which makes it a Sell.
-
Seres Therapeutics 50-day exponential moving average is 0.78 while MCRB share price is 0.74, making it a Sell technically.
-
MCRB stock price is 0.74 and Seres Therapeutics 200-day simple moving average is 0.96, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics
Is Seres Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.16 per share, an increase this year of $0.35 per share, and a decrease next year of $0.20 per share.
Technical Analysis of Seres Therapeutics
Should I short Seres Therapeutics stock?
-
MCRB Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Seres Therapeutics is a Sell
-
Seres Therapeutics Relative Strength Index (RSI) is 48.24, which suggest Seres Therapeutics is oversold
-
The Bollinger Bands (25) for Seres Therapeutics is (0.71 - 0.81), which suggest Seres Therapeutics is a Sell
-
The Bollinger Bands (100) for Seres Therapeutics is (0.71 - 0.89), which suggest Seres Therapeutics is a Sell
* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.